Kerrie L. Mcdonald

Sydney, NSW 2040, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Microglia and brain macrophages are differentially associated with tumor necrosis in glioblastoma: A link to tumor progression.

Microglia and brain macrophages are differentially associated with tumor necrosis in glioblastoma: A link to tumor progression.

Journal: Oncology research

Published: July 23, 2024

NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma.

NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma.

Journal: Neuro-oncology advances

Published: October 16, 2023

Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419).

Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419).

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 29, 2023

Human prefrontal cortex gene regulatory dynamics from gestation to adulthood at single-cell resolution.

Human prefrontal cortex gene regulatory dynamics from gestation to adulthood at single-cell resolution.

Journal: Cell

Published: October 29, 2021

DLL3 expression and methylation are associated with lower-grade glioma immune microenvironment and prognosis.

DLL3 expression and methylation are associated with lower-grade glioma immune microenvironment and prognosis.

Journal: Genomics

Published: September 28, 2021

Physical activity and glioma: a case-control study with follow-up for survival.

Physical activity and glioma: a case-control study with follow-up for survival.

Journal: Cancer causes & control : CCC

Published: September 10, 2021

TP53 Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy.

TP53 Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy.

Journal: Cancers

Published: September 09, 2021

A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study.

A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study.

Journal: Neuro-oncology

Published: May 13, 2021

Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma.

Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma.

Journal: Frontiers in molecular biosciences

Published: November 25, 2020

PathoFusion: An Open-Source AI Framework for Recognition of Pathomorphological Features and Mapping of Immunohistochemical Data.

PathoFusion: An Open-Source AI Framework for Recognition of Pathomorphological Features and Mapping of Immunohistochemical Data.

Journal: Cancers

Published: October 08, 2020

Lanthanum nanoparticles to target the brain: proof of biodistribution and biocompatibility with adjuvant therapies.

Lanthanum nanoparticles to target the brain: proof of biodistribution and biocompatibility with adjuvant therapies.

Journal: Nanomedicine (London, England)

Published: September 02, 2020

Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobanking.

Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobanking.

Journal: Neuro-oncology practice

Published: April 08, 2020

Showing 1-12 of 71

Last Updated: 09/26/2026